Validation study of MARCKSL1 as a prognostic factor in lymph node-negative breast cancer patients.
Protein expression of Myristoylated alanine-rich C kinase substrate like-1 (MARCKSL1) has been identified as a prognostic factor in lymph-node negative (LN-) breast cancer patients. We aim to validate MARCKSL1 protein expression as a prognostic marker for distant metastasis-free survival (DMFS) in a...
Main Authors: | Nina Gran Egeland, Marie Austdal, Bianca van Diermen-Hidle, Emma Rewcastle, Einar G Gudlaugsson, Jan P A Baak, Ivar Skaland, Emiel A M Janssen, Kristin Jonsdottir |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0212527 |
Similar Items
-
Prognostic value of gene signatures and proliferation in lymph-node-negative breast cancer.
by: Kristin Jonsdottir, et al.
Published: (2014-01-01) -
Validation of expression patterns for nine miRNAs in 204 lymph-node negative breast cancers.
by: Kristin Jonsdottir, et al.
Published: (2012-01-01) -
The Prognostic Value of the Proliferation Marker Phosphohistone H3 (PPH3) in Luminal, Basal-Like and Triple Negative Phenotype Invasive Lymph Node-Negative Breast Cancer
by: Ivar Skaland, et al.
Published: (2009-01-01) -
LOH at 1p31 (ARHI) and Proliferation in Lymph Node-Negative Breast Cancer
by: Emiel A. M. Janssen, et al.
Published: (2009-01-01) -
Mitotic activity index and CD25+ lymphocytes predict risk of stage progression in non-muscle invasive bladder cancer.
by: Melinda Lillesand, et al.
Published: (2020-01-01)